The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA)

Autor: Salah Ghabri, Erwan Autin, Anne-Isabelle Poullié, Jean Michel Josselin
Přispěvatelé: Haute Autorité de Santé [Saint-Denis La Plaine] (HAS), Centre de recherche en économie et management (CREM), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS), Normandie Université (NU)-Normandie Université (NU)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)
Rok vydání: 2017
Předmět:
Budgets
medicine.medical_specialty
health expenditure
Cost-Benefit Analysis
analyse d’impact budgétaire
Psychological intervention
MEDLINE
guide méthodologique
health interventions
Accounting
Guidelines as Topic
Health administration
03 medical and health sciences
0302 clinical medicine
Political science
Health care
medicine
Humans
budget impact analysis
030212 general & internal medicine
health care economics and organizations
Pharmacology
Haute Autorité de santé
Health economics
French Authority for Health
business.industry
030503 health policy & services
Health Policy
Public health
Public Health
Environmental and Occupational Health
Equity (finance)
methodological guidelines
interventions de santé
Public consultation
[SHS.ECO]Humanities and Social Sciences/Economics and Finance
3. Good health
dépenses de santé
France
0305 other medical science
business
Zdroj: PharmacoEconomics
PharmacoEconomics, 2018, 36 (4), pp.407-417. ⟨10.1007/s40273-017-0602-5⟩
PharmacoEconomics, Springer Verlag, 2018, 36 (4), pp.407-417. ⟨10.1007/s40273-017-0602-5⟩
ISSN: 1179-2027
1170-7690
Popis: International audience; Background - Budget impact analysis (BIA) provides short- and medium-term estimates on changes in budgets and health outcomes resulting from the adoption of new health interventions. Objective - The purpose of this study is to present the newly developed French National Authority for Health (HAS) guidelines on budget impact analysis as follows: process, literature review, recommendations and comparisons with other guidelines. Methods - The development process of the HAS guidelines included a literature review (search dates: January 2000 to June 2016), a retrospective investigation of BIA previously submitted to HAS, a public consultation, international expert reviews and approval from the HAS Board and the Economic and Public Health Evaluation Committee of HAS. Results - Documents identified in the literature review included 12 national guidelines, 5 recommendations for good practices developed by national and international society of health economics and 14 methodological publications including recommendations for conducting BIA. Based on its research findings, HAS developed its first BIA guidelines, which include recommendations on the following topics: BIA definition, perspective, populations, time horizon, compared scenarios, budget impact models, costing, discounting, choice of clinical data, reporting of results and uncertainty exploration. Conclusion - It is expected that the HAS BIA guidelines will enhance the usefulness, quality and transparency of BIA submitted by drug manufacturers to HAS. BIA is becoming an essential part of a comprehensive economic assessment of healthcare interventions in France, which also includes cost-effectiveness analysis and equity of access to healthcare.
Databáze: OpenAIRE
Externí odkaz: